The U.S. Preventive Services Task Force today recommended clinicians offer pre-exposure prophylaxis (PrEP), a pill that helps prevent the spread of HIV, to high-risk patients. High-risk behaviors include having a sex partner with HIV, having sex without a condom with a partner at high risk for HIV and sharing needles or other equipment while injecting drugs, the panel said. PrEP is highly effective at preventing HIV if taken daily, but people who take the pill should continue to use condoms and practice other behaviors to reduce their risk of other sexually transmitted infections, the task force said. It also continued to recommend that clinicians screen for HIV in pregnant women, everyone aged 15 to 65, and others at increased risk for HIV. The panel assigned an “A" grade to the recommendations, meaning all copays and deductibles would be waived under the Affordable Care Act.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Dec. 11 announced the launch of the Make America Healthy Again: Enhancing Lifestyle and Evaluating Value-based…
Headline
A study published Dec. 3 by the New England Journal of Medicine found that one dose of the HPV vaccine could be as effective as two in preventing cervical…
Headline
The Centers for Medicare & Medicaid Services Innovation Center will launch a new, outcome-aligned payment model for providers offering technology-supported…
Headline
The House Ways and Means Subcommittee on Health held a hearing Nov. 19 to discuss improvements to care coordination and delivery to prevent and treat chronic…
Headline
Elizabeth Dabrowski, M.D., pediatric endocrinologist at Children’s Wisconsin, and Matthew Edwards, R.D., diabetes care and education specialist at Children’s…
Headline
The American Heart Association released a study Oct. 28 that found disruptions to people’s circadian rhythm can increase their risk of cardiovascular disease…